-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Targeting Aggressive NK-Cell Leukemia and Other CD94-Expressing NK/T-Cell Lymphoproliferative Disorders with CAR T-Cell Therapy

Program: Special-Interest Sessions
Session: Hematology Inclusion Pathway (HIP) Oral Presentations - Malignant Hematology
Saturday, December 7, 2024, 6:00 PM-9:00 PM

Owhofasa Agbedia

MD Anderson Cancer Center, houston, TX

Disclosures: No relevant conflicts of interest to declare.

See more of: Hematology Inclusion Pathway (HIP) Oral Presentations - Malignant Hematology
See more of: Special-Interest Sessions
<< Previous Presentation | Next Presentation